Wolverine Trading
LUMO

Wolverine Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Wolverine Trading’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,200
Closed -$90K – 5391
2020
Q1 		$90K Buy
10,200
+7,067
+226% +$98.8K ﹤0.01% 4067
2019
Q4 		$65K Sell
3,133
-1,878
-37% -$26.8K ﹤0.01% 4399
2019
Q3 		$74K Buy
+5,011
New +$73.5K ﹤0.01% 3943
2018
Q1 		– Sell
-3,289
Closed -$240K – 5986
2017
Q4 		$240K Sell
3,289
-155
-5% -$12.8K ﹤0.01% 3912
2017
Q3 		$316K Buy
3,444
+2,266
+192% +$174K ﹤0.01% 3185
2017
Q2 		$78K Buy
+1,178
New +$146K ﹤0.01% 3968
2017
Q1 		– Sell
-2,289
Closed -$212K – 5180
2016
Q4 		$212K Sell
2,289
-2,033
-47% -$229K ﹤0.01% 3700
2016
Q3 		$571K Sell
4,322
-1,200
-22% -$119K ﹤0.01% 2438
2016
Q2 		$543K Buy
+5,522
New +$684K ﹤0.01% 2154

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFG
Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Wolverine Trading's LUMO Position: Q1 2020 in Review

Wolverine Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 2,761 shares — an estimated $38.6K sold.

Wolverine Trading first reported a position in LUMO in Q2 2016 and held it in 6 quarters. The position peaked at $389K in Q3 2016. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

  • Wolverine Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Wolverine Trading sold 2,761 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $38.6K.
  • Wolverine Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
  • Wolverine Trading's Lumos Pharma, Inc. Common Stock position peaked at $389K in Q3 2016.
  • 46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Wolverine Trading's 13F filing for Q1 2020, filed 11 May 2020.